Integra Lifesciences Holdings Corp (IART)

Price$16.49Cached quote
IARTNasdaq
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

18 annual periodsNewest to oldest
202520242023202220212020201920182017201620152014201320122011201020092008
Revenue$1.64B$1.61B$1.54B$1.56B$1.54B$1.37B$1.52B$1.47B$1.19B$992.1M$882.7M$796.7M$696.8M$830.9M$780.1M$732.1M$682.5M$654.6M
Gross profit$831.6M$882.1M$884.7M$970.3M$944.6M$851.0M$952.9M$900.9M$752.7M$643.0M$556.2M$493.8M$417.3M$516.4M$480.9M$463.9M$437.6M$401.8M
Gross margin50.86%54.77%57.39%62.29%61.24%62.03%62.79%61.19%63.35%64.81%63.01%61.98%59.88%62.16%61.65%63.37%64.11%61.38%
Research & development$99.0M$115.4M$104.2M$101.2M$93.1M$77.4M$79.6M$78.0M$63.5M$58.2M$50.9M$43.6M$42.6M$51.0M$51.5M$48.1M$44.3M$60.5M
Operating expenses$2.13B$1.58B$1.43B$1.32B$1.35B$1.22B$1.42B$1.36B$1.14B$876.7M$476.6M$425.9M$381.9M$442.7M$426.0M$365.2M$339.7M$354.4M
Operating income−$493.4M$28.4M$111.5M$238.9M$197.2M$151.4M$93.8M$111.0M$44.8M$115.3M$79.6M$67.9M$35.4M$73.8M$54.9M$98.7M$97.8M$47.4M
Operating margin−30.17%1.76%7.23%15.34%12.79%11.03%6.18%7.54%3.77%11.63%9.02%8.52%5.08%8.88%7.04%13.48%14.33%7.24%
EBITDA−$433.6M$92.1M$164.8M$292.9M$253.5M$221.2M$203.2M$221.7M$133.7M$188.0M$138.4M$114.3M$66.4M$126.4M$105.1M$137.9M$137.5M$78.1M
EBITDA margin−26.52%5.72%10.69%18.80%16.44%16.13%13.39%15.06%11.26%18.95%15.68%14.35%9.53%15.21%13.47%18.83%20.15%11.94%
Net income−$516.5M−$6.9M$67.7M$180.6M$169.1M$133.9M$50.2M$60.8M$64.7M$74.6M−$3.5M$34.0M−$21.1M$41.2M$28.0M$65.7M$51.0M$27.7M
Net profit margin−31.58%−0.43%4.39%11.59%10.96%9.76%3.31%4.13%5.45%7.52%−0.40%4.27%−3.02%4.96%3.59%8.97%7.47%4.24%
Basic EPSper basic share-$6.74-$0.09$0.85$2.18$2.00$1.58$0.59$0.73$0.84$1.00-$0.05$0.52-$0.19$0.37$0.24$0.55$0.44$0.25
Diluted EPSper diluted share-$6.74-$0.09$0.84$2.16$1.98$1.57$0.58$0.72$0.82$0.94-$0.05$0.52-$0.19$0.36$0.24$0.54$0.44$0.24

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 20 reported holders of IART
HolderShares held
BlackRock, Inc.
10.68M
Rubric Capital Management LP
7.75M
Invesco Ltd.
3.75M
VANGUARD PORTFOLIO MANAGEMENT LLC
3.74M
MORGAN STANLEY
3.59M
PARADIGM CAPITAL MANAGEMENT INC/NY
3.44M
FULLER & THALER ASSET MANAGEMENT, INC.
3.44M
STATE STREET CORP
2.95M
VANGUARD CAPITAL MANAGEMENT LLC
2.95M
NEUBERGER BERMAN GROUP LLC
2.36M
DIMENSIONAL FUND ADVISORS LP
2.22M
GEODE CAPITAL MANAGEMENT, LLC
1.79M
ESSIG STUART
1.79M
GOLDMAN SACHS GROUP INC
1.47M
WELLINGTON MANAGEMENT GROUP LLP
1.46M
MILLENNIUM MANAGEMENT LLC
1.44M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
1.4M
BANK OF AMERICA CORP /DE/
1.33M
SYSTEMATIC FINANCIAL MANAGEMENT LP
1.02M
Allianz Asset Management GmbH
1.01M

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys1$102.2K disclosed value
Sells (SEC code S)3$166.9K disclosed value
4 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Nov 5, 2025Form 4GRAVES JEFFREY ADirectorBuyCommon Stock9.0K$11.35$102.2K41.1K
Dec 3, 2024Form 4Schwartz EricEVP, Chief Legal Officer & SecSellCommon Stock4.1K$24.60$100.1K59.5K
Dec 2, 2024Form 4McBreen Michael J.EVP & President, CSSSellCommon Stock1.7K$24.16$41.1K56.2K
Aug 19, 2024Form 4Mosebrook JeffreySVP, Fin & Princ Acct OfficerSellCommon Stock1.2K$21.58$25.7K36.1K

Community posts

It’s quiet here.

No posts about IART yet. Start the conversation.

Write the first post